British Pharmacopoeia Commission – Member (Reappointment)Announced
|Appointing Department:||Department of Health and Social Care|
|Number of Vacancies:||1|
An announcement has been made on the outcome of this appointment.
Seven members have been reappointed to the British Pharmacopoeia Commission (BPC) from 1 January 2020. Dr Anna-Maria Brady, Dr Alison Gleadle (lay member) and Ms Sharon Palser (lay member) have been reappointed for 4 years. Dr Jon Beaman, Mr Robert Lowe and Professor Monique Simmonds have been reappointed for 3 years. Professor Alastair Davidson has been reappointed for 2 years.
The members are entitled to claim a fee of £325 per meeting (preparation and attendance). The time commitment is 3 meetings per year. Members will also be required to attend meetings of the Expert Advisory Groups (EAG) or Panels of Experts to which they are appointed. This will be for a maximum of 2 meetings per EAG each year.
These appointments are made in accordance with the Cabinet Office Code of Governance for Public Appointments. The regulation of public appointments against the requirements of this code is carried out by the Commissioner for Public Appointments.
The reappointments are made on merit and political activity played no part in the decision process. However, in accordance with the code, there is a requirement for appointees’ political activity (if any declared) to be made public. None of the reappointed members have declared any political activity. Dr Jon Beaman has declared that he is employed by a pharmaceutical company and any potential conflicts of interest are declared at the beginning of any discussion.
These reappointments are made jointly between the Secretary of State for Health and Social Care and the Minister for Health, Social Services and Public Safety (Northern Ireland), and in consultation with Scottish Ministers.
Date: 03/03/2020View Announcement
This is a reappointmentReturn to Search